Ventilator-induced lung injury is characterised by inflammation and apoptosis, but the underlying mechanisms are poorly understood. The present study proposed a role for angiotensin-converting enzyme (ACE) via angiotensin II (Ang II) and/or bradykinin in acute lung injury. The authors assessed whether ACE and, if so, Ang II and/or bradykinin are implicated in inflammation and apoptosis by mechanical ventilation. Rats were ventilated for 4 h with low- or high-pressure amplitudes in the absence or presence of the ACE inhibitor captopril. Nonventilated animals served as controls. ACE activity, Ang II and bradykinin levels, as well as inflammatory parameters (total protein, macrophage inflammatory protein-2 and interleukin-6) were determined. Apoptosis was assessed by the number of activated caspase-3 and TUNEL (terminal deoxynucleotidyltransferase-mediated deoxyuridine triphosphate nick-end labelling)-positive cells. Bronchoalveolar lavage fluid ACE activity, levels of total protein, inflammatory parameters and the number of apoptotic cells were increased in the high-pressure amplitude group as compared with the control group. Blocking ACE activity by captopril attenuated inflammation and apoptosis in the latter group. Similar results were obtained by blocking Ang II receptors, but blocking bradykinin receptors did not attenuate the anti-inflammatory and anti-apoptotic effects of captopril. The current authors conclude that inflammation and apoptosis in ventilator-induced lung injury is, at least in part, due to angiotensin-converting enzyme-mediated angiotensin II production. Copyright

Additional Metadata
Keywords Angiotensin-converting enzyme, Apoptosis, Captopril, Inflammation, Ventilator-induced lung injury
Persistent URL dx.doi.org/10.1183/09031936.00060207, hdl.handle.net/1765/29867
Note Free full text at PubMed
Citation
Wösten-van Asperen, R.M, Lutter, R, Haitsma, J.J, Merkus, M.P, van Woensel, J.B, van der Loos, C.M, … Bos, A.P. (2008). ACE mediates ventilator-induced lung injury in rats via angiotensin II but not bradykinin. The European Respiratory Journal, 31(2), 363–371. doi:10.1183/09031936.00060207